Company profile
Home - Accentus Medical
Accentus Medical Limited is a UK company with status active founded in 2001 based in South East England.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxNDE3NzE3OGFkaXF6a2N4
Published 02 Apr 2026 20:16
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 May 2023 to 31 Oct 2024
Accentus is a UK-based medtech SME with a core project team of Philip Agg (CEO), James Shawcross (R&D Director), Andrew Turner (Principal Scientist), David Lewis (Laboratory Manager) and Agnes Gardner (Process Technician). Surgical site infections (SSIs) greatly diminish patient quality of life, as an intended treatment leads to complications that often r...
1 Oct 2017 to 30 Sep 2018
The project will develop and evaluate a novel silver based anti-microbial surface treatment for application to complex orthopaedic device materials. The project will build on Accentus Medical's previous successful commercialisation of its proprietary Agluna® silver ion based anti-microbial technology for conventional titanium orthopaedic device surfaces. ...
1 Dec 2015 to 29 Feb 2016
Awaiting Public Project Summary
1 Jul 2015 to 31 Mar 2016
Accentus Medical Limited is seeking to commercialise Acusure Ag, its innovative silver ion based antimicrobial hydroxyapatite coating for orthopaedic implants. This project will transition the production process from a laboratory setting, to demonstration of a scaled-up manufacturing process enabling cost-effective commercial supply to Accentus Medical’s ...
